In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species
about
Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interactionEpidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus FungiChronic invasive aspergillosis caused by Aspergillus viridinutans.Evaluation of amphotericin B and chloramphenicol as alternative drugs for treatment of chytridiomycosis and their impacts on innate skin defenses.Fungal infections in transplant and oncology patients.Invasive aspergillosis due to Neosartorya udagawaeCryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance.Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis.Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection modelAntifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, JapanRapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature.E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesisResistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis.Antifungal Susceptibility Testing of Aspergillus spp. by Using a Composite Correlation Index (CCI)-Based Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Method Appears To Not Offer Benefit over Traditional Broth MicrodilActivity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007).Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methodsTherapeutic drug monitoring of posaconazole: a monocentric study with 54 adults.Screening of a large global Aspergillus fumigatus species complex collection by using a species-specific microsphere-based Luminex assay.In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.New generation azole antifungals in clinical investigation.Pharmacology and clinical use of voriconazole.In vitro susceptibility testing in Aspergillus species: an update.Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections.Epidemiology and antifungal resistance in invasive Aspergillosis according to primary disease: review of the literature.Update on the optimal use of voriconazole for invasive fungal infections.Invasive aspergillosis: resistance to antifungal drugs.Antifungal therapy in children: an update.Azole resistance in Aspergillus: global status in Europe and Asia.Invasive aspergillosis in the intensive care unit.Antifungal agents in current pediatric practice.Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections.Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.Use of a high-resolution melt assay to characterize codon 54 of the cyp51A gene of Aspergillus fumigatus on a Rotor-Gene 6000 instrument.
P2860
Q26864717-07682F98-CF34-4DB3-900F-B8F746B45E45Q28068091-E6D91B3A-75EC-46A9-B8FA-5475748C8FC0Q33628715-F8CEFDAC-C971-4C03-9755-D7C52E81CE67Q33743364-B17669D8-67F7-4B83-985A-AD04DE2C799AQ33896940-E965C5E2-9F10-4483-9E91-5D3B32CED357Q33909352-E3319229-AB92-41E9-97E9-8BEFCA502791Q34298083-D60512D8-753A-48A0-8D6B-AF50AF65347CQ34621506-95F650B1-2D53-402E-B8F5-ACBB1BCE6DFFQ34933141-8C2BEB69-8C25-4C98-A889-AC04327EB640Q35066763-5F3AE865-13D0-4288-B2EE-FF0CCD7B3FA1Q35270948-B637500F-ED1C-4326-B4F1-48589E3D32B8Q35385554-61A3B94D-99BF-4693-BB46-F411FD770DCBQ35666518-C35F3FAE-4563-4BF8-817E-7C3F7024E6B3Q35666591-F90B5292-6A25-4573-B6D7-B8D844F7914AQ35689250-E389F23D-9B90-48DE-87CD-87742CE166BDQ36118607-7E986DAD-9392-42AD-89DA-FC4B0BDC6B03Q36345309-2C9E854F-26B3-4082-A97F-1B6ED2FADBA7Q37213981-44C4FABF-D97B-416F-AD13-8756E323BA4DQ37374804-011DE3D1-8ECC-455F-B3DC-DA38068C0B5CQ37374949-3FBC54D8-908D-46BD-96C3-B83F37790554Q37450660-B8E7674A-34F1-4850-BC0B-2593B0A5D87EQ37451709-EAAA9F50-AE95-4B97-92AE-BE44DADB61FDQ37497644-C10695F8-D7E9-4146-B480-A17F4A4208BFQ37579222-77576619-4B61-4506-9883-BEE6DD3FC9E0Q37641375-8E7CD1D0-0605-4FA2-8D6E-08BD1ED7FAACQ37742178-3CAAFEC7-7098-48CD-8A7E-0EE63AC73DBBQ37810091-2BC4C4C5-1A75-42E1-BC1D-5F5F17238C33Q37813420-A5934C53-1F08-469F-9797-9A3C150B0281Q37864427-7C4DCFDD-843B-4147-8414-AE0EF32BF9A0Q37892901-33D59696-86FB-4EFC-837A-B6C19FBA1FA2Q37983464-059C87AE-9B84-4F6D-9431-C76D9A3C84B2Q38015090-9C733E2E-704F-4DC9-8201-11C8A93BCA4EQ38066613-2A1ADB73-F552-4422-9208-CA4A254B8A73Q38066616-6BA23145-249C-4A58-BACD-83558A47263DQ38101520-82CDB53E-7363-43ED-83B5-6A2CF70BAEB7Q38103889-7FE7F4F9-A3B5-49AC-B302-EA7C992A4E55Q38283306-4C370EF2-B581-4462-92A5-ABF76F3D3CB2Q38711698-C7E43A31-F0F2-438C-919D-9B1781BADC24Q38880522-34B5FB1B-AF43-4D47-A6FB-E45A10627C3CQ40336978-A684AAF3-E553-4EDE-B849-CAACD114DF24
P2860
In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
In vitro survey of triazole cr ...... solates of Aspergillus species
@en
In vitro survey of triazole cr ...... solates of Aspergillus species
@nl
type
label
In vitro survey of triazole cr ...... solates of Aspergillus species
@en
In vitro survey of triazole cr ...... solates of Aspergillus species
@nl
prefLabel
In vitro survey of triazole cr ...... solates of Aspergillus species
@en
In vitro survey of triazole cr ...... solates of Aspergillus species
@nl
P2093
P2860
P356
P1476
In vitro survey of triazole cr ...... solates of Aspergillus species
@en
P2093
P2860
P304
P356
10.1128/JCM.00535-08
P407
P577
2008-06-18T00:00:00Z